The effect of transforming growth factor β (TGF-β) on the biosynthesis of individual proteoglycans (PGs) by human embryonic lung fibroblasts has been investigated using specific antibodies and cDNA probes. Human lung fibroblasts secrete the two small chondrotin/dermatan sulfate PGs, PG-I or biglycan (300 kDA) and, in a larger proportion, PG-II or decorin (130 kDa). Metabolic labeling experiments reveal that TGF-β induces selectivity the expression of PG-I, whereas the level of PG-II remains unaltered. The effect of TGF-β on PG-I and PG-II has been studied by immunoprecipitation and Northern blot analysis. Either at the core protein or mRNA level, a specific 5-fold increase in PG-I can be observed. TGF-β acts probably at the transcriptional level, as actinomycin D blocks completely the TGF-β induced proteoglycan synthesis. A low saturation density and a slower growth rate is also observed for TGF-β treated cells. The possible role of PG-I and PG-II as mediators of the growth inhibition caused by TGF-β is discussed. © 1991.
- (Human embryonic lung fibroblast)
- Proteoglycan synthesis
- Transforming growth factor